Ionizing radiation is the primary non-surgical treatment modality for solid tumors. Its effectiveness is impacted by temporal constraints such as fractionation, hypoxia and development of radioresistant clones. Biomarkers of acute radiation response are essential to developing more effective clinical algorithms. We hypothesized that acute perturbations in tumor lactate levels act as a surrogate marker of radiation response. In vitro experiments were carried out using validated human derived cell lines from 3 histologies: anaplastic thyroid carcinoma (ATC), head and neck squamous cell carcinoma (HNSCC) and papillary thyroid carcinoma (PTC). Cellular metabolic activity was measured using standard biochemical assays. In vivo validation was performed using both an orthotopic and a flank derivative of a previously established ATC xenograft murine model. Irradiation of cells and tumors triggered a rapid, dosedependent, transient decrease in lactate levels which was reversed by free radical scavengers.
Introduction
Ionizing radiation (IR) is the most effective spatially distributed non-surgical cancer treatment.(1, 2) Through continued technological improvements in IR delivery, definitive treatment doses can now be delivered with decreased toxicity and improved efficacy. (3) Continued improvement in the therapeutic index of IR requires approaches with sufficient temporal resolution to address optimal fractionation, adaptation to transient hypoxia and synergistic incorporation of radiosensitizing agents. (4) It has been shown, by our group and others, that IR cytotoxicity is largely mediated through generation of reactive oxygen species (ROS) resulting in DNA damage.(5-10) IRinduced ROS perturb cellular metabolism in a measurable and quantifiable manner which could theoretically be exploited for therapeutic purposes. (5) Our group has demonstrated a proportional relationship between IR-induced ROS levels and cell death, and showed that this relationship at least partially accounts for some of the radioresistance encountered in solid tumors. (6, 8) This relationship identifies an important therapeutic window to target radioresistant tumors, such as those driven by mutations in TP53. (6, 8) Although high levels of ROS are essential to achieving a therapeutic effect, basal ROS play an important role in tumorigenesis and metastasis. (11, 12) Because of this dual role, quantitative measurements of tumor cell and tumor ROS are important to maximize therapeutic efficacy and decrease normal tissue toxicity.
Lactate is a metabolite well known to correlate with changes in tissue ROS levels. This relationship has been shown to be important in both normal aging and oncogenic transformation. (15, 16) Unfortunately, data generated by this trial failed to demonstrate a correlation between proton magnetic resonance spectroscopic measurements of lactate signal intensity and clinical outcomes. (16) These data generated a puzzling contradiction between the biochemical promise of lactate and the inability to successfully achieve clinical translation. It has been long established, in both pre-clinical (17, 18) and clinical series (19, 20 ) that hypoxia exerts a profound impact on in vivo radiation effects (21). Matsumoto et al. demonstrated convincingly that lactate perturbations identify hypoxic conditions, a known correlate with induced radioresistance. (22) Furthermore, these metabolic alterations can be linked to genomic alterations such as TP53.(23) Since radiation effectiveness is also mediated by temporal constraints (e.g. fractionation, transient hypoxia, shifting tumor vascularity) we sought to focus on the hightemporal resolution detection of radiation-induced lactate perturbations. Specifically, as microenvironemental lactate levels have long been held as a harbinger of altered radioresistance (24), we hypothesized that IR-induced ROS perturbations are mirrored by rapid changes in tumor cell lactate levels in a measurable and quantifiable manner. This hypothesis is based on previous studies by our group which found that magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized 13 C pyruvate can detect acute changes in tumor lactate levels following metabolic inhibition and/or irradiation. (5) In this study, we sought to determine whether measurements of acute lactate changes provide a consistent and reliable means of detecting genotoxic stress with a temporal resolution suitable for clinical translation. To confirm translational relevance we aimed to demonstrate the following: 1) dose-dependent relationship between acute, transient changes in lactate levels and IR exposure; 2) correlation with acquired (i.e. hypoxia) and/or intrinsic (TP53 mutation) radioresistance; and 3) generalizability across multiple histologies. Metabolic studies. For lactate, NAD+ and NADH measurements cells were harvested at various time points (0, 15, 30, 60 and 120 min) post-irradiation (0, 2 and 5 Gy) and/or drug treatment using appropriate buffers and snap-frozen in liquid nitrogen. Lactate, NAD+ and NADH levels were analyzed by colorimetric assays using commercially available assays (BioVision, Milpitas, CA), according to the manufacturer's instructions.
Cytotoxicity studies. Drug and IR cytotoxicity were assayed using clonogenic assays. Cells were treated with 1mM 2-deoxyglucose for 24 hours, in normoxic (21% O 2 ) or hypoxic (1% O 2 achieved using hypoxia chamber or CoCl2 exposure) conditions, then irradiated using a high dose-rate 137 Cs unit (Mark I-68A,4.5 Gy/min) to the indicated dose (0-6 Gy). Four hours postirradiation, fresh media were replaced and cells were incubated for colony formation for 10-14 days, then fixed and stained using a 1% formalin/ crystal violet solution. Colonies were counted and surviving fractions were determined based upon the plating efficiency of the non-irradiated control group. 
Results
Oxidative stress perturbs ATC cellular reducing potential. ATC cells were grown under standard conditions and exposed to 2-DG, a known inhibitor of glycolysis and a compound previously shown by us and others to decrease the global cellular reducing potential. (6, 26, 27) This resulted in a significant increase in NAD+ levels (75%) and a drop in the ratio of NADH/NAD+ (50%) consistent with a predicted decrease in reducing potential (Supplemental Figure 1A ). These effects were reproduced by exogenous administration of H 2 O 2 (Supplemental 8 decreased in response to both agents, and effect which was reversed in a concentrationdependent manner by NAC ( Figure 2B ). Consistent with effects on cellular reducing potential, IR exposure decreased lactate production acutely in a dose-dependent manner; this was reversed by NAC ( Figure 2C ). This dose-dependent decrease in tumor cell lactate levels correlates with the dose-dependent increase in cell death following irradiation demonstrated using clonogenic survival ( Figure 2C ). In order to further test the link between ROS and lactate levels following irradiation, H 2 O 2 was used to increase tumor cell ROS levels. This resulted in a correspondent increase in the magnitude of tumor cell lactate changes following irradiation, in contrast to the effects of NAC, which restores lactate levels following irradiation (Supplemental Figure 3) . cells. In order to confirm that this differential response is driven by loss of p53 function, we tested the effect of IR on cellular lactate levels using a previously described pair of constructs.
As shown in Figure 5 , HN30 cells in which p53 activity was decreased by shRNA interference demonstrated a blunted response to IR compared to lentiviral vector transfected HN30 control cells. At 5 Gy, the drop in lactate levels in shp53 cells was 49% at 15 minutes and 72% at 30 minutes post irradiation. These quantitative differences were reproducible across multiple replicates and experimental series as well as multiple IR doses (Supplemental Figure 5) . 
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Specifically, at the lower dose of 2 Gy, the lactate drop in cells with suppressed p53 activity (shp53) was only 36% of that of lentiviral transfected control cells at 15 minutes post-irradiation and 59% at 30 minutes post-irradiation. These data are consistent with our previously published data regarding the relative radioresistance/radiosensitivity of this pair of constructs (Supplemental Figure 6) . (6, 8) We further validated the relationship between cellular lactate levels and acute radiation exposure in a multiple ATC and PTC cell lines. As shown in Figure 6 Tumor hypoxia demonstrates not only spatial (40) but temporal heterogeneity as well (41), with acute and chronic components (42) . Immunohistochemical means of assessing tumor hypoxia are static, and the use of existing metabolic imaging methods are constrained by tumor sizeassociated spatial heterogeneity (43) , variable tracer-specific time dependencies (44) , and reported discordance with direct measurement in specific tumor histologies (45) . Within a time frame of minutes, lactate levels can be used to distinguish radiation response in hypoxic conditions from its normoxic correlate in a manner consistent with acquired radioresistance. (5) illustrates average data from control and irradiated tumor groups. B) Control (n=5) and irradiated (n=5; 5 Gy) orthotopic xenograft tumors were harvested immediately post-irradiation.
Dynamic integration of this approach via HP-MRSI
Tissue levels of lactate were measured and normalized to total protein levels. 
